
Entertainment
By TrendScope Daily Staff · October 26, 2026
Warner Bros. and DC Studios finally found out what happens when you build a studio tentpole around a villain nobody expected to carry a movie. Clayface opened in U.S. theaters on October 23, 2026, took the No. 1 spot domestically with an estimated $24.5 million, and landed a rare A- CinemaScore for a horror release. It also, by Monday, had become the latest data point in a pattern that’s starting to worry people inside James Gunn’s DC Universe: the movies look fine at home and soft everywhere else.
A body-horror villain movie with no Batman in sight
Directed by James Watkins from a screenplay by Mike Flanagan and Hossein Amini (story by Flanagan), Clayface is the third film in Gunn and Peter Safran’s rebooted DC Universe and the first entry billed as “Chapter One: Gods and Monsters” to skip capes entirely. Tom Rhys Harries stars as Matt Hagen, a disfigured actor who volunteers for an experimental treatment that restores his face and then slowly turns his body into living, shapeshifting clay. Naomi Ackie, Max Minghella, Eddie Marsan and David Dencik round out the cast.
The film carries an R rating for “strong bloody violence, gore, language, some nudity and brief drug use,” and producer Peter Safran has compared its tone to David Cronenberg’s The Fly rather than anything campy or comic-booky. At a reported $44 million budget — modest by superhero-movie standards — it was built as a contained horror film that happens to live inside a shared universe, not a four-quadrant blockbuster.
The opening weekend, by the numbers
Per Deadline’s Sunday estimates, Clayface grossed $24.5 million domestically from 3,458 theaters, with a Friday-to-Sunday breakdown of $10.6 million, $7.8 million and $5.6 million. That put it at the very top of Deadline’s own $20 million to $25 million projection, but notably short of other trackers’ forecasts in the low-to-mid $30 millions, and short of what the studio itself had reportedly hoped for — a range of $25 million to $35 million. Presales had been the softest of any DCU title to date, so simply winning the weekend and beating the conservative read counts as a win of sorts.
It didn’t have to fight hard for first place. Fourth-place finisher Street Fighter, in its second weekend, fell 72% to $8.6 million for a 10-day domestic total of $46.9 million. The real story of the weekend’s No. 2 spot was Nathan Fielder’s Elizabeth Holmes documentary You Can See Everything, which actually grew 25% to $19.5 million after A24 expanded it from 855 to 2,655 theaters, pushing its total past $45 million.
A rare A- from horror audiences
Audiences liked what they saw more than the opening number alone suggests. Clayface earned a CinemaScore of A-, a grade horror movies almost never reach, and an 94% audience score on Rotten Tomatoes against a more measured 75% from critics — the kind of gap that typically signals strong word of mouth once a film is out of the “unproven” bucket. James Gunn noted on social media that only Ryan Coogler’s Sinners has ever scored a full A from CinemaScore in the horror genre, and that Obsession, Weapons, and now Clayface make up the short list of horror films to hit A- in the last couple of years. Premium large-format screens accounted for close to half the film’s gross, even though it played in zero IMAX locations — an unusual split that suggests the audience skewed toward people actively seeking out the biggest, loudest version of the experience. Nearly three-quarters of ticket buyers were between 18 and 34.
The overseas problem
Here’s where the weekend gets less comfortable for Warner Bros. Clayface pulled in roughly $43 million worldwide through Sunday, well below Variety’s pre-weekend projection of $45 million to $55 million across 76 international markets. International theaters contributed only about $18.5 million of that total — around 43% of the global gross — which is a strikingly similar overseas share to what both Superman and Supergirl posted earlier in Gunn’s DCU run. Three films in, the pattern looks less like a fluke and more like a structural problem with how these movies are traveling abroad.
That matters because of the math underneath a $44 million production: industry estimates put the break-even point, once marketing is factored in, at roughly $110 million worldwide. After three days, Clayface hadn’t reached even half of that figure. A strong back half of its run — helped by that A- CinemaScore and the Halloween-weekend timing it was deliberately moved to capture — could still get it there. But it isn’t the kind of runaway start that erases doubts about the DCU’s export appeal.
Where this leaves Gunn’s DC Universe
For context, June’s Supergirl opened domestically to $37.1 million — about $12.6 million more than Clayface — and still finished at only $126.4 million worldwide, a result reportedly projected to lose the studio as much as $244 million. Against that bar, a profitable-if-unspectacular run for a $44 million horror film is a relatively low-risk outcome, even with the soft international start. Gunn has described himself as “really proud” of the film, and Watkins has said the full reveal of Clayface’s creature design was deliberately kept out of marketing until release — a bet on word of mouth over trailer spectacle that the CinemaScore and audience numbers suggest may be paying off, even as the global rollout lags behind.
The bigger question is what “Chapter One: Gods and Monsters” is supposed to prove. If the strategy is smaller, cheaper, genre-first stories that live inside a shared universe without leaning on it, Clayface‘s domestic opening and A- grade are exactly the kind of signal Gunn needs. If the goal is still a globally dominant blockbuster machine to rival Marvel at its peak, three straight underwhelming international openings in a row is the number that needs to change before the next chapter begins.
For DC fans who want to keep the character around after the credits roll, a Clayface Funko Pop figure is widely available and makes for an easy shelf addition alongside the rest of a DCU collection.
As an Amazon Associate, TrendScope Daily earns from qualifying purchases made through links in this article.